Taga Y, Hayashida O, Kusubata M, Ogawa-Goto K, Hattori S
In response to our concerns, the applicant commented that it is committed to providing the clinical evidence necessary to satisfy the substantial clinical improvement standard and indicated that it is currently conducting an ongoing prospective, multicenter, open-label, single-arm clinical study [44] to evaluate the Axoguard HA+ Nerve Protector TM in patients undergoing a first revision cubital tunnel decompression procedure for recurrent or recalcitrant cubital tunnel syndrome
Several plant extracts have emerged as promising candidates in enhancing GLP-1 activity or mimicking its metabolic benefits
Methylcobalamin in the Treatment of Sleep Disorders Research has shown that Methylcobalamin can impact melatonin production and may be beneficial, in treating sleep disorders in individuals, with sleep patterns
Many different types of anemia can exist in patients
Others assign more conservative windows of 14 to 28 days